
Sign up to save your podcasts
Or


Joe and Eric speak with Charley Hooper, author of the book Should the FDA Reject Itself? Part one of their discussion explores the likely impact of the Inflation Reduction Act and its drug pricing provisions, which include: overall drug production, the total impact on inflation, as well as the irony of prices actually going up as a result. *Episode aired Oct 26, 2022*
By Stay On Course Studios5
1212 ratings
Joe and Eric speak with Charley Hooper, author of the book Should the FDA Reject Itself? Part one of their discussion explores the likely impact of the Inflation Reduction Act and its drug pricing provisions, which include: overall drug production, the total impact on inflation, as well as the irony of prices actually going up as a result. *Episode aired Oct 26, 2022*

153,925 Listeners

4,274 Listeners

4,878 Listeners

695 Listeners

6,606 Listeners

322 Listeners

3,342 Listeners

34 Listeners

40,513 Listeners

6,236 Listeners

716 Listeners

453 Listeners

8,781 Listeners

16,984 Listeners

1,425 Listeners